Navigation Links
Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc.
Date:4/7/2009

"I am excited to be part of WellGen," said Dr. Carter. "The market is now ready, as never before, for the introduction of natural products that provide therapeutic benefits based on their impact on gene expression. I look forward to leading the team as we develop WellGen's pipeline of products and achieve success in the emerging field of medical foods."

Dr. Carter received his medical degree from the University of the Witwatersrand and then a Master of Science degree in Sports Medicine from Trinity College, Dublin.

About Amphion:

Amphion Innovations (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has a significant shareholding in eight Partner Companies and two specialized entities, developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. On the web: www.amphionplc.com

About WellGen

WellGen, Inc., based in North Brunswick, N.J., is a life science company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomx(TM), a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic niches for WellGen's pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing pr
'/>"/>

SOURCE WellGen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
2. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
3. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
4. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
5. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
6. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
7. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
10. Kendle Named a Best Place to Work in Greater Cincinnati
11. Sinovac Named to Deloitte Technology Fast 50 China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... - Development of a Novel ... VOLVOX Platform - To be Presented on Tuesday, Apr ... Assembly of Antibody-drug Conjugates Using an anti-HER2 Monoclonal Antibody ... Apr 19, 1:00 PM EST Invictus Oncology ... announced that the company,s novel computational platform technology (VOLVOX) ...
(Date:4/20/2015)... April 20, 2015 Global Stem ... Aesthetic Meeting 2015, an annual gathering of aesthetic medicine ... M.D., is scheduled to introduce the company’s brand new ... with adipose-derived stem cell techniques. , The course ... patients in the aesthetic field, including facial aging caused ...
(Date:4/17/2015)... 17, 2015 Reed Technology and ... regulatory data management, preparation, and submission to the U.S. ... of a new Lot Distribution Report (LDR) service for ... remain compliant with the FDA’s new rule on electronic ... to monitor the volume and timing of particular biologics ...
(Date:4/17/2015)... drug discovery company, Novogen, today announced that it ... Feinstein Institute for Medical Research (,Feinstein Institute,) of ... with the objective of developing effective treatments for ... the drug discovery expertise of Novogen and the ... in neurosciences and oncology. At the ...
Breaking Biology Technology:Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal 2Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal 3Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6
... CLEVELAND, Jan. 21 Last year the NorTech Venture,Capital ... Capital,Report that the region would need to generate and ... order to meet the capital needs of companies,located in ... 2007 Venture Capital Report of the Cleveland+ region, to ...
... of Women,s Ovarian ... Reserve, ... the first IVF center in the southeast to offer,the Repromedix Plan Ahead(TM) ... supply by combining multiple factors,including the measurement of ovary-related hormones AMH, Inhibin ...
... activity in patients with ... NNRTI-resistant virus -, ... Drug,Administration (FDA) has granted accelerated approval to the anti-HIV,medication INTELENCE ... show antiviral activity in,treatment- experienced adult patients with HIV resistant ...
Cached Biology Technology:Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 2Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 3Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 4Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 5Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 2Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 3FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 2FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 3FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 4FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 5FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 6FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 7FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 8
(Date:3/31/2015)...  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant ... Defined Network Architecture (ET Software DNA® 2.0) platforms and ... $20.4 million for the year ended December 31, 2014 ... year ended December 31, 2013. At ... its multi-year transition away from its legacy landline business ...
(Date:3/24/2015)... Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of ... report to their offering. This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ...
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... of Anatomists, 2012 Basmajian Award will be presented on ... department of cell biology, neurobiology and anatomy at the ... place at the AAA Annual Meeting at EB 2012 ... San Diego, CA)., This award recognizes health science faculty ...
... predators also had beefier arm bones, finds a new fossil ... extinct cats weren,t the only animals with fearsome fangs. Take ... and their catlike cousins, a family of carnivores called the ... of years before cats came to be, and had knife-like ...
... Hydrogen sulfide, a gas notorious for its rotten-egg smell, may ... of scarring proteins in kidney cells, researchers from The University ... Journal of Biological Chemistry. The paper is scheduled ... manufacture of scarring proteins , "There is interest in ...
Cached Biology News:Todd Hoagland honored by Anatomy Society for excellence in teaching, research & scholarship 2Prehistoric predators with supersized teeth had beefier arm bones 2Prehistoric predators with supersized teeth had beefier arm bones 3Hydrogen sulfide reduces glucose-induced injury in kidney cells 2
...
Contains L-glutamine....
Contains L-glutamine...
... Clone/PAD: ZMD.358. Immunogen: Synthetic ... region of human mouse and ... with human and mouse LRP5 ... (positive controls: mouse LRP5-pSEC-tag-transfected 293T ...
Biology Products: